References
- DalbethNMerrimanTRStampLKGoutLancet2016388100552039205227112094
- DalbethNPoolBGambleGDCellular characterization of the gouty tophus: a quantitative analysisArthritis Rheum20106251549155620131281
- ChoiHKAtkinsonKKarlsonEWCurhanGObesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up studyArch Internal Med2005165774274815824292
- KöttgenAAlbrechtETeumerAGenome-wide association analyses identify 18 new loci associated with serum urate concentrationsNat Genet201345214515423263486
- MerrimanTRAn update on the genetic architecture of hyperuricemia and goutArthritis Res Ther2015179825889045
- DoyleLAYangWAbruzzoLVA multidrug resistance transporter from human MCF-7 breast cancer cellsProc Natl Acad Sci U S A1998952615665156709861027
- WongKBriddonSJHollidayNDKerrIDPlasma membrane dynamics and tetrameric organisation of ABCG2 transporters in mammalian cells revealed by single particle imaging techniquesBiochim Biophys Acta201618631192926453803
- XuJLiuYYangYBatesSZhangJTCharacterization of oligomeric huma half-ABC transporter ATP-binding cassette G2J Biol Chem2004279197811978915001581
- AllenJDBrinkhuisRFWijnholdsJSchinkelAHThe mouse Bcrp1/Mxr/Abcp gene amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicinCancer Res199959174237424110485464
- RossDDYangWAbruzzoLVAtypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell linesJ Natl Cancer Inst199991542943310070941
- LeslieEMDeeleyRGColeSPMultidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defenseToxicol Applied Pharmacol20052043216237
- PadmanabhanRChenKGGilletJPRegulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cellsStem Cells201230102175218722887864
- SzepesiÁMatulaZSzigetiAABCG2 is a selectable marker for enhanced multilineage differentiation potential in periodontal ligament stem cellsStem Cells Dev2014242244252
- WagenerFADankersACvan SummerenFHeme oxygenase-1 and breast cancer resistance protein protect against hemeinduced toxicityCurr Pharmaceutical Design2013191526982707
- JonkerJWBuitelaarMWagenaarEThe breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyriaProc Natl Acad Sci U S A20029924156491565412429862
- HorseyAJCoxMHSarwatSKerrIDThe multidrug transporter ABCG2: still more questions than answersBiochemical Soc Trans2016443824830
- WoodwardOMKöttgenAKöttgenMABCG transporters and diseaseFEBS J2011278183215322521554546
- DehghanAKöttgenAYangQAssociation of three genetic loci with uric acid concentration and risk of gout: a genome-wide association studyLancet200837296541953196118834626
- WoodwardOMKottgenACoreshJBoerwinkleEGugginoWBKottgenMIdentification of a urate transporter, ABCG2, with a common functional polymorphism causing goutProc Natl Acad Sci U S A200910625103381034219506252
- SaisonCHeliasVBallifBANull alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system JuniorNat Genet201244217417722246505
- ZelinskiTCoghlanGLiuX-QReidMEABCG2 null alleles define the Jr (a-) blood group phenotypeNat Genet201244213113222246507
- DeppeSRippergerAWeissJErgünSBenndorfRAImpact of genetic variability in the ABCG2 gene on ABCG2 expression, function, and interaction with AT1 receptor antagonist telmisartanBiochem Biophys Res Comm201444341211121724388985
- ImaiYNakaneMKageKC421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistanceMol Cancer Ther20021861161612479221
- KobayashiDIeiriIHirotaTFunctional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placentaDrug Metab Dispos20053319410115475413
- KondoCSuzukiHItodaMFunctional analysis of SNPs variants of BCRP/ABCG2Pharm Res200421101895190315553238
- MizuaraiSAozasaNKotaniHSingle nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2Int J Cancer2004109223824614750175
- MorisakiKRobeyRWÖzvegy-LaczkaCSingle nucleotide polymorphisms modify the transporter activity of ABCG2Cancer Chemother Pharmacol200556216117215838659
- TamuraAWakabayashiKOnishiYRe-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2Cancer Sci200798223123917297656
- FurukawaTWakabayashiKTamuraAMajor SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradationsPharm Res200926246947918958403
- PrasadBLaiYLinYUnadkatJDInterindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotypeJ Pharm Sci2013102378779323280364
- LeeJYKinchLNBorekDMCrystal structure of the human sterol transporter ABCG5/ABCG8Nature201653356156427144356
- WoodwardOMTukayeDNCuiJGout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small moleculesProc Natl Acad Sci U S A20131105223522823493553
- SarankóHTordaiHTelbiszAEffects of the gout-causing Q141K polymorphism and a CFTR ∆508 mimicking mutation on processing and stability of the ABCG2 proteinBiochem Biophys Res Commun2103437140145
- YuWKim ChiawPBearCEProbing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutantJ Biol Chem2011286247142472521602569
- WoodwardOMABCG2: the molecular mechanisms of urate secretion and goutAm J Physiol Renal Physiol2015309F485F48826136557
- BassevilleATamakiAIeranoCHistone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporterCancer Res201272143642365122472121
- RippergerABenndorfRAThe C421A (Q141K) polymorphism enhances the 3′-untranslated region (3′-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2Biochem Pharmacol201610413914726903388
- ToKKRobeyRWKnutsenTZhanZRiedTBatesSEEscape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2Mol Cancer Ther20098102959296819825807
- NakanishiTRossDDBreast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expressionChin J Cancer201231739922098950
- HeXWangJWeiWHypoxia regulates ABCG2 activity through the activation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cellsCancer Biol Ther20161718819826785721
- KrishnamurthyPRossDDNakanishiTThe stem cell marjer Bcrp/ABCG2 enhances hypoxic cell survival through interactions with hemeJ Biol Chem20042792412824225
- MogiMYangJLambertCFAkt signaling regulates side population cell phenotype via Bcrp1 translocationJ Biol Chem2003278390683907512851395
- BleauAMHambardzumyanDOzawaTPTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cellsCell Stem Cell20096226235
- HuCFHuangYYWangYJGaoFGUpregulation for ABCG2 via the PI3K-Akt pathway contributes to acidic microenvironment-induced cisplatin resistance in A549 and LTEP-a-2 ling cancer cellsOncol Rep20163645546127221310
- HuangFFZhangLWuDSPTEN regulates BCRP/ABCG2 and the side population through the PI3K/Akt pathway in chronic myeloid leukemiaPLoS One20149e8829824603487
- JiaYChenJZhuHJiaZHCuiMHAberrantly elevated redox sensing factor Nrf2 promotes cancer stem cell survival via enhanced transcriptional regulation of ABCG2 and Bcl-2/Bmi-1 genesOncol Rep20153452296230426324021
- WangJZhuXXLiuLSIRT1 prevents hyperuricemia via the PGC-1α/PPARγ-ABCG2 pathwayEndocrine20165344345227022940
- SzatmariIVamosiGBrazdaPPeroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cellsJ Biol Chem2006281238122382316785230
- EePLKamalakaranSTonettiDIdentification of a novel estrogen responsive element in the breast cancer resistance protein geneCancer Res20041512471251
- EvseenkoDAPaxtonJWKeelanJAIndependent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factorsDrug Metab Disppos200735595601
- ChangFWFanHCLiuJMEstrogen enhances the expression of the multidrug transporter gene ABCG2 – increasing drug resistance of breast cancer cells through estrogen receptorsInt J Mol Sic201718E163
- ChangW-CWuY-JJChungW-HGenetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritisRheumatology201756345746628394398
- Galmés-PascualBMNadal-CasellasABauza-ThorbrüggeM17β-estradiol imrpoves hepatic mitochondrial biogenesis and function through PGC1BJ Endcrinol2017232297308
- HentschkeMSüsensUBorgmeyerUPGC-1 and PERC, coactivators of the estrogen receptor-related receptor gammaBiochem Biophys Res Commun200229987287912470660
- ScarpullaRCTranscriptional paradigms in mammalian mitochondrial biogenesis and functionPhysiol Rev20088861163818391175
- MerrimanTRBoocockJDalbethNMitochondrial genetic variation and susceptibility to gout in PolynesiansAnn Rheum Dis201675S2115
- MerrimanTTerkeltaubRPPARGC1B: insight into the expression of the gouty inflammation phenotype: PPARGC1B and gouty inflammationRheumatology201756332332528003496
- OkadaYSimXGoMJMeta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populationsNat Genet201244890490922797727
- CharlesBAShrinerDDoumateyAA genome-wide association study of serum uric acid in African AmericansBMC Med Genomics201141721294900
- TinAWoodwardOMKaoWHLGenome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function alleleHum Mol Genet201120204056106821768215
- RenYCJinTBSunXDPKD2 and ABCG2 genes polymorphisms are correlated with blood glucose levels and uric acid in Tibetan gout patientsGenet Mol Res201615
- SullJWYangSJKimSJeeSHThe ABCG2 polymorphism rs2725220 is associated with hyperuricemia in the Korean populationGenom Inform201412231235
- ShimizuTSugiuraTWakayamaTPDZK1 regulates breast cancer resistance protein in small intestineDrug Metab Dispos201139112148215421816982
- HuffmanJEAlbrechtETeumerAModulation of genetic associations with serum urate levels by body-mass-index in humansPLoS One2015103e011975225811787
- SpeliotesEKWillerCJBerndtSIAssociation analyses of 249,796 individuals reveal 18 new loci associated with body mass indexNat Genet2010421193794820935630
- StahlEChoiHCadzowMFlynnTToplessRMerrimanTRConditional analysis of 30 serum urate loci identifies 25 additional independent effectsArthritis Rheum201466S1294
- WenCYeeSLiangXGenome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug responseClin Pharm Therap2015975518525
- JiriMZhangLLanBGenetic variation in the ABCG2 gene is associated with gout risk in the Han Chinese populationClin Rheumatol20163515916326506822
- TuH-PKoAM-SChiangS-LJoint effects of alcohol consumption and ABCG2 Q141K on chronic tophaceous gout riskJ Rheumatol201441474975824532835
- ZhouDLiuYZhangXFunctional polymorphisms of the ABCG2 gene are associated with gout disease in the Chinese Han male populationInt J Mol Sci20141559149915924857923
- HulsMBrownCDAWindassASThe breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membraneKidney Int20087322022517978814
- MandalAKMountDBThe molecular physiology of uric acid homeostasisAnn Rev Physiol20157732334525422986
- MatsuoHTakadaTIchidaKCommon defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese populationSci Trans Med2009155ra11
- IchidaKMatsuoHTakadaTDecreased extra-renal urate excretion is a common cause of hyperuricemiaNat Commun2012376422473008
- MatsuoHNakayamaASakiyamaMABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overloadSci Rep20144375524441388
- TorresRJde MiguelEBailénRTubular urate transporter gene polymorphisms differentiate patients with gout who have normal and decreased urinary acid excretionJ Rheumatol201441186387025128519
- KannangaraDRPhipps-GreenAJDalbethNHyperuricemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urateAnn Rheum Dis2016751363136626835700
- DalbethNHouseMGambleGDInfluence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challengeArthritis Res Ther201430R34
- KimYSKimYParkGGenetic analysis of ABCG2 and SLC2A9 gene polymorphisms in gouty arthritis in a Korean populationKorean J Intern Med201530691326552468
- LiCLiZLiuSGenome-wide association analysis identifies three new risk loci for gout arthritis in Han ChineseNat Commun20156704125967671
- MatsuoHYamamotoKNakaokaHGenome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypesAnn Rheum Dis201675465265925646370
- Phipps-GreenAJHollis-MoffattJDalbethNA strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Maori, case and control sample setsHum Mol Genet2010194813481920858603
- WanWXuXZhaoDBPangYFWangYXPolymorphisms of uric acid transporter proteins in the pathogenesis of gout in a Chinese Han populationGenet Mol Res2015142546155025867401
- StarkKReinhardWGrasslMCommon polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary heart diseasePLoS One20094e772919890391
- Phipps-GreenAMerrimanMToplessRTwenty-eight loci that influence serum urate levels: analysis of association with goutAnn Rheum Dis20167512413025187157
- MerrimanTRPhipps-GreenABoocockJPleiotropic effect of ABCG2 in gout2016 ACR/ARHP Annual MeetingNovember 11–16, 2016Washington, DC Abstract Number 2276
- HeWPhipps-GreenAStampLKMerrimanTRDalbethNPopulation-specific association between ABCG2 variants and tophaceous disease in people with goutArthritis Res Ther2017194328270222
- XiaCQLiuNMiwaGTGanLSInteractions of cyclosporin a with breast cancer resistance proteinDrug Metab Dispos20073557658217220244
- LinHYRocherLLMcQuillanMDCyclosporine-induced hyperuricemia and goutN Engl J Med19903223343362296276
- WatsonSDigiacintoJLDavisMWEffect of cyclosporine on the pharmacokinetics of colchicine in healthy subjectsPostgrad Med201212418919622913907
- MartinonFPetrilliVMayorATardivelATschoppJGout-associated uric acid crystals activate the NALP3 inflammasomeNature2006440708123724116407889
- SkeldonAMFarajMSalehMCaspases and inflammasomes in metabolic inflammationImmunol Cell Biol201492430431324518981
- Giamarellos-BourboulisEJMouktaroudiMBodarECrystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1β by mononuclear cells through a caspase 1-mediated processAnn Rheum Dis200968227327818390571
- JoostenLANeteaMGMylonaEEngagement of fatty acids with toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal–induced gouty arthritisArthritis Rheum201062113237324820662061
- ThackerSGZarzourAChenYHigh-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activationImmunology2016149330631927329564
- Williams-BeyYBoularanCVuralAOmega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-κB activation and enhancing autophagyPLoS One201496e9795724911523
- QingYFZhouJGZhangQBAssociation of TLR4 gene rs2149356 polymorphism with primary gouty arthritis in a case-control studyPLoS One20138e6484523738004
- RasheedHMcKinneyCStampLKThe toll-like receptor 4 (TLR4) variant rs2149356 and risk of gout in European and Polynesian sample setsPLoS One201611e1047939
- ChenYRenXLiCCARD8 rs2034211 polymorphism is associated with gout in a Chinese male populationCell Physiol Biochem2015351394140025790751
- LeeSWLeeSSOhDHGenetic association for P2X7R rs3751142 and CARD8 rs2043211 polymorphisms for susceptibility of gout in Korean men: multi-center studyJ Korean Med Sci2016311566157027550484
- McKinneyCStampLKDalbethNMultiplicative interaction of functional inflammasome genetic variants in determining the risk of goutArthritis Res Ther20151728826462562
- ShenSCallaghanDJuzwikCXiongHHuangPZhangWABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer’s diseaseJ Neurochem201011461590160420626554
- SautinYYNakagawaTZharikovSJohnsonRJAdverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stressAm J Physiol20072932C584C596
- LanaspaMASanchez-LozadaLGChoiY-JUric acid induces hepatic steatosis by generation of mitochondrial oxidative stress potential role in fructose-dependent and-independent fatty liverJ Biol Chem201228748407324074423035112
- van der HeijdenJWOerlemansRTakPPInvolvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomideArthritis Rheum200960366967719248091
- von Wedel-ParlowMWoltePGallaHJRegulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitroJ Neurochem2009111111111819656257
- PollerBDreweJKrahenbuhlSHuwylerJGutmannHRegulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrierCell Mol Neurobiol2010301637019629677
- Le VeeMLecureurVStiegerBFardelORegulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6Drug Metab Dispos200937368569319074973
- DingRJinSPabonKScottoKWA role for ABCG2 beyond drug transport: Regulation of autophagyAutophagy201612573775126983466
- ZhongZUmemuraASanchez-LopezENF-κB restricts inflammasome activation via elimination of damaged mitochondriaCell2016164589691026919428
- ZhouRYazdiASMenuPTschoppJA role for mitochondria in NLRP3 inflammasome activationNature2011469732922122521124315
- JhangJJChengYTHoCYYenGCMonosodium urate crystals trigger Nrf2- and heme oxygenase-1-dependent inflammation in THP-1 cellsCell Mol Immunol201512442443425109682
- ToKKRobeyRZhanZBangioloLBatesSEUpregulation of ABCG2 by romidepsin via the aryl hydrocarbon receptor pathwayMol Cancer Res20119451652721357443
- BeckerMSchumacherHRWortmannRFebuxostat compared with allopurinol in patients with hyperuricaemia and goutN Engl J Med20053532450246116339094
- StampLMerrimanTBarclayMInadequate response to allopurinol in the treatment of gout – defining the population and potential causesSemin Arthritis Rheum201444217017424925693
- SaitoYStampLCaudleKClinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Human Leukocyte Antigen B (HLA-B) Genotype and Allopurinol Dosing: 2015 updateClin Pharm Ther20169913637
- RobertsRWallaceMPhipps-GreenAABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with goutPharmacogenomics J Epub2016126
- TurnheimKKrivanekPOberbauerRPharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjectsBr J Clin Pharmacol199948450150910583019
- BhatnagarVRichardELWuWAnalysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signalingClin Kidney J20169344445327274832
- YanoHTamuraYKobayashiKTanemotoMUchidaSUric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney diseaseClin Exp Nephrol2014181505523584883
- WuWDnyanmoteAVNigamSKRemote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesisMol Pharmacol201179579580521325265
- AmesBNCathcartRSchwiersEHochsteinPUric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesisProc Natl Acad Sci U S A19817811685868626947260
- Desuzinges-MandonEArnaudOMartinezLABCG2 transports and transfers heme to albumin through its large extracellular loopJ Biol Chem201028543331233313320705604
- BellomoGVenanziSVerduraCAssociation of uric acid with change in kidney function in healthy normotensive individualsAm J Kidney Dis201056226427220385436
- RobinsonPCChoiHKDoRMerrimanTRInsight into rheumatological cause and effect through the use of Mendelian randomizationNat Rev Rheumatol201612848649627411906
- HughesKFlynnTde ZoysaJDalbethNMerrimanTRMendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal functionKidney Int201385234435124048376
- TestaAMallamaciFSpotoBAssociation of a polymorphism in a gene encoding a urate transporter with CKD progressionClin J Am Soc Nephrol2014961059106524742479
- DankersACMutsaersHADijkmanHBHyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP)Biochim Biophys Acta20131832101715172223665398
- CrișanTOCleophasMCOostingMSoluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1RaAnn Rheum Dis201675475576225649144
- KaszaIVáradyGAndrikovicsHExpression levels of the ABCG2 multidrug transporter in human erythrocytes correspond to pharmacologically relevant genetic variationsPLoS One20127e4842323166586
- LiRMiaoLXiangYA meta-analysis of the associations between the Q141K and Q126X ABCG2 gene variants and gout riskInt J Clin Exp Pathol201589812982326617691
- DongZGuoSYangYAssociation between ABCG2 Q141K polymorphism and gout risk affected by ethnicity and gender: a systematic review and meta-analysisInt J Rheum Dis20151838239125639607